2004 Computational Chemistry Pharmaceuticals 
Sygnature Discovery
JULY 31, 2023
Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology.
Sygnature Discovery
MARCH 24, 2022
When DMPK scientist Lynette Ongeri joined Sygnature this month, she unknowingly helped us reach a landmark we couldn’t be prouder of… Sygnature Discovery – or Sygnature Chemical Services Ltd, as it was known then – opened its doors in 2004 with five colleagues. Back to Lynette, though.
Drug Target Review
SEPTEMBER 20, 2023
Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D. To really benefit from AI, the pharmaceutical industry must be more open to data sharing. Matthew subsequently put his computational chemistry skills to use in the defence sector.
Expert insights. Personalized for you.
52 
Let's personalize your content